Katy Moore, PharmD, RPh
President
We have the same mission as you:
Develop and deliver essential medicines to the patients who need them. We do this through deep collaboration to understand your needs, increasing your confidence in decision making and delivering innovative strategies.
By translating complex data into actionable insights that informs dosing, study designs, and modeling, the Allucent Clinical Pharmacology, Modeling & Simulation (CPMS) team can help deliver on your next breakthrough.
Our Expertise
350+
Years experience in
all phases of drug
development
650+
Drugs supported: all
modalities, routes of
administration and
therapeutic areas
6,650+
PK, PD, TK, QTc
translational
analyses
500+
Clients supported
400+
PopPK and E-R
modeling, dose, and
trial simulations
2,800+
IND, CTA, NDA, MAA,
BLA, ANDA, PIP, PSP,
505(b)(2)+
520+
Clinical study
protocols, reports,
publications
CLINICAL PHARMACOLOGY MODELING & SIMULATION
From clinical pharmacology strategy to pharmacokinetic (PK) & pharmacodynamic (PD) assessment and Model Informed Drug Development (MIDD). We bring our passion for innovation, unparalleled expertise and partnership approach.
We are Allucent. Our focus is you.
Meet Your A-Team
At Allucent, we’re your trusted partner for navigating the complexities of drug development. With unparalleled expertise and a global perspective, our diverse team of pharmacology experts is here to guide your study to success.
Allucent excels in Clinical Pharmacology Modeling and Simulation (CPMS). Our team of experts integrates seamlessly into your drug development team, using industry-leading technology, quality processes, and tailored solutions to drive success. From candidate selection to regulatory approval, we provide the insights and strategies you need.
- Led numerous organizations in clinical pharmacology and MIDD strategy
- >25 years in pharmaceutical industry
- 42 published manuscripts
Lisa Benincosa, PhD
SVP,
Clinical Pharmacology Strategy
- Held executive leadership positions at several large pharmaceutical companies
- Expertise in translational medicine, clinical pharmacology, and DMPK
Alex MacDonald, PhD
VP, Global Head of Model-Informed Drug Development
- 25 years+ industry experience with senior positions at Novartis, Roche, GSK, and AstraZeneca
- Deep expertise in clinical pharmacology, MIDD and drug development
- Published across multiple, complex therapeutic areas
EXPERIENCE THE TRANSFORMATIVE POWER OF OUR EXPERTISE
Partner with Allucent to unlock the future of drug development and propel your success.
Why Allucent Clinical Pharmacology Modeling and Simulation (CPMS)?
ADDRESSING YOUR CHALLENGES
Dig into the Details of Allucent’s CPMS Expertise
At Allucent, we’re your trusted partner for navigating the complexities of drug development. With unparalleled expertise and a global perspective, our diverse team of pharmacology experts is here to guide your study to success.
Our commitment to your success is underscored by an unwavering dedication to excellence.
UNLOCK THE FUTURE WITH ALLUCENT’S CPMS EXPERTISE
Allucent’s commitment to excellence is etched in our track record of satisfied clients and impactful outcomes.
Partner with us, and together, let’s reshape the future of drug development. Your success is our goal, and your aspirations are the driving force that propels us forward. Connect with us today, and let’s forge ahead toward a horizon illuminated by possibilities
BEGIN YOUR JOURNEY OF SUCCESS.
Partner With the A-Team
Let us know how we can help you bring new therapies to light. Get in touch to get started.
Join the A-Team
Want to help small and mid-sized biotech companies change the therapeutic landscape?